XML 56 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Investments (Details 4) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net sales $ 78,786 $ 212,242
Gross profit 74,827 210,743
BioFirst [Member]    
Net sales 12,110 10,334
Gross profit 1,578 1,882
Net loss (325,652) (307,034)
Share of losses from investments accounted for using the equity method (70,411) (66,205)
Rgene [Member]    
Net sales
Gross profit
Net loss (21,889) (22,662)
Share of losses from investments accounted for using the equity method